Please provide your email address to receive an email when new articles are posted on . Some patients with new-onset diabetes may have symptoms that are indicative of both type 1 and type 2 diabetes.
Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results